» Articles » PMID: 38792432

Long-Term Adherence to Continuous Positive Airway Pressure in Patients with Obstructive Sleep Apnoea Set Up in a Complete Remote Pathway: A Single-Centre Service Evaluation Project

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 May 25
PMID 38792432
Authors
Affiliations
Soon will be listed here.
Abstract

: Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep apnoea (OSA). Maintaining adherence to CPAP in the long term is a clinical problem, and numerous factors have been identified that impact adherence. Although fully remote diagnostic and CPAP services were frequently utilised during the COVID-19 pandemic for patients with OSA, long-term adherence data have not been published. The aim of this service evaluation project was to describe the long-term adherence to CPAP. We also analysed factors that are associated with it. : two-hundred and eighty patients diagnosed with OSA and set up on CPAP remotely during the first wave of the COVID-19 pandemic as part of routine clinical practice were analysed. : One-hundred and seven patients (38%) were fully adherent to CPAP at 24 months, determined by at least 4 h of usage on at least 70% of the days. Of the factors analysed, body mass index, disease severity, driving status and the presence of depression were related to long-term adherence (all < 0.05). : with the likelihood of future pandemics similar to COVID-19, our data provide evidence that fully remote pathways for management of patients with OSA can be designed and be sustainable with good long-term adherence.

Citing Articles

Mitigating Increased Cardiovascular Risk in Patients with Obstructive Sleep Apnea Using GLP-1 Receptor Agonists and SGLT2 Inhibitors: Hype or Hope?.

Karakasis P, Sagris M, Patoulias D, Koufakis T, Theofilis P, Klisic A Biomedicines. 2024; 12(11).

PMID: 39595069 PMC: 11591904. DOI: 10.3390/biomedicines12112503.


Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review.

Dragonieri S, Portacci A, Quaranta V, Carratu P, Lazar Z, Carpagnano G Diseases. 2024; 12(9).

PMID: 39329893 PMC: 11431450. DOI: 10.3390/diseases12090224.

References
1.
Grote L, McNicholas W, Hedner J . Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA). Eur Respir J. 2020; 55(6). PMC: 7236823. DOI: 10.1183/13993003.01323-2020. View

2.
Meurling I, Birdseye A, Gell R, Sany E, Brown R, Higgins S . The effect of a change from face-to-face to remote positive airway pressure education for patients with sleep apnoea during the coronavirus disease-2019 pandemic: a prospective cohort study. J Thorac Dis. 2023; 15(2):820-828. PMC: 9992574. DOI: 10.21037/jtd-22-1816. View

3.
Kohler M, Smith D, Tippett V, Stradling J . Predictors of long-term compliance with continuous positive airway pressure. Thorax. 2010; 65(9):829-32. DOI: 10.1136/thx.2010.135848. View

4.
Drake C, Day R, Hudgel D, Stefadu Y, Parks M, Syron M . Sleep during titration predicts continuous positive airway pressure compliance. Sleep. 2003; 26(3):308-11. DOI: 10.1093/sleep/26.3.308. View

5.
Randerath W, Verbraecken J, de Raaff C, Hedner J, Herkenrath S, Hohenhorst W . European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea. Eur Respir Rev. 2021; 30(162). PMC: 9489103. DOI: 10.1183/16000617.0200-2021. View